A team of chemists from the University of California, Davis, recently demonstrated that a new synthetic analogue of cannabidiol (CBD) may be just as effective for medicinal uses as its naturally extracted counterpart. This synthetic CBD compound also promises to be easier, cheaper and faster to produce. Last year the FDA approved CBD for the treatment of two rare forms of severe childhood-onset epilepsies. This milestone moment marked the first approval...